Pharmaceuticals

Sort by Latest
Badmouthing Your Competitor’s Products: When Does Denigration Become an Antitrust Issue?
Over the past decade, different competition authorities across Europe have begun to identify and pursue...
February 20, 2020
25 min read
Changes in the Polish Industrial Law concerning Patents
Recent changes to the Polish Industrial Law concerning patents (enacted in October 2019), are due to...
February 13, 2020
4 min read
UK Supreme Court hearing appeal over permitted breadth of patent claims
Yesterday and today the Supreme Court has been hearing an appeal concerning Regeneron's...
February 12, 2020
12 min read
Distribution of Free Samples of Medicinal Products to Pharmacists: The Court is requested to settle an Important Issue
The European and national legislations regulate the relationship between healthcare professionals and...
February 11, 2020
4 min read
More Guidance on Pharma Settlement Agreements from the Court of Justice of the EU (ECJ)
It is clear that under certain specific circumstances, a settlement agreement between a holder of a pharmaceutical...
February 7, 2020
11 min read
The US/China Trade Agreement: what could it mean for the Pharma Industry?
Following a long period of negotiation, Phase I of the US-China Trade Agreement was published on 15 January...
February 6, 2020
5 min read
Access to toxicity reports and protection of commercial interests: the Court of Justice of the European Union blows the final whistle!
The Court of Justice of the European Union (CJEU) has recently issued two rulings which aim at ending...
February 4, 2020
8 min read
Bird & Bird: Setting a gold standard in meeting cannabis regulation
Medical Cannabis Network speaks with Bird & Bird’s Ben King and Sally Shorthose about the importance...
January 24, 2020
13 min read
Access to toxicity study reports and protection of commercial interests
Gerard Hogan, Advocate General at the Court of Justice of the European Union (“CJEU”) recently...
November 22, 2019
8 min read
The English Patents Court examines the law on enablement in the context of lack of novelty based on both prior publication and prior use.
Earlier this year (17 July 2019) in Takeda UK Limited v F. Hoffmann-La Roche AG Mr Justice Colin Birss...
November 19, 2019
5 min read